Janelle Glover, PA-C

Janelle Glover practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Janelle Glover's NPI, 1942728217, was assigned on September 6, 2017. Janelle Glover holds California license PA59693.

Janelle Glover's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Janelle Glover's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Janelle Glover is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Janelle Glover to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Janelle Glover practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Janelle Glover's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Janelle Glover's licenses on file in 2 states: California and Maryland.

Dmand AI lists chronic lung disease and enlarged prostate among the conditions Janelle Glover treats.

CMS data shows 201 Medicare services from Janelle Glover across 6 procedure codes in 2024, for 144 Medicare patients. Medicare paid $11,711 for them.

CMS counts 144 Medicare patients who saw Janelle Glover in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Janelle Glover's median patient age at 72, with 22% women.

In 2024, Janelle Glover wrote 276 Medicare Part D claims for 121 patients. 86% of them were for generic drugs. CMS names the drug for 209 of them, across 7 drugs with 11 or more claims each, at $24,002 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Janelle Glover for performance year 2024, reported as part of a group. Janelle Glover accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Janelle Glover as offering telehealth.

CMS Open Payments shows 4 general payments to Janelle Glover from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $142.